ALGM
Allegro MicroSystems, Inc.
ALGM's outlook is improving despite an expensive valuation.
NVDA
NVIDIA Corporation
NVDA has the edge over ALGM overall, supported by stronger valuation and stronger modeled upside.
ALGM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
ALGM's revenue, profitability, cash flow and balance sheet are all currently healthy.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
ALGM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 25x | $3.95 | -88% |
| Forward | 25x | $31.71 | — |
| Fair | 42x | $6.66 | -79% |
| Expensive | 60x | $9.54 | -70% |
| Current | 198x | $31.71 | — |
Historical ranges are pointers, not guarantees.
ALGM's PE is in its expensive range at 198x. If earnings grow as analysts expect, today's price would be 25x next year's earnings, in its cheap range.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over ALGM in the historical PE scenario, which offers more potential upside but is not a forecast.
ALGM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
ALGM has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
ALGM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | +696% |
| Q3 2026 | $0.16 | +$0.32 |
| Q2 2026 | $0.07 | +$0.44 |
| Q1 2026 | -$0.08 | +$0.31 |
| Q4 2025 | -$0.08 | +$0.27 |
| Q3 2025 | -$0.16 | -$0.02 |
| Q2 2025 | -$0.37 | -197% |
| Q1 2025 | -$0.39 | -150% |
| Q4 2024 | -$0.35 | -130% |
ALGM has returned to profit: it earned $0.16 per share over the past year, after losing money the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over ALGM on earnings, with more consistent year-over-year improvement.
ALGM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $276.9M | +29% |
| Q2 2026 | $259.2M | +27% |
| Q1 2026 | $243.2M | +26% |
| Q4 2025 | $229.2M | +29% |
| Q3 2025 | $214.3M | +14% |
| Q2 2025 | $203.4M | +22% |
| Q1 2025 | $192.8M | -20% |
| Q4 2024 | $177.9M | -30% |
ALGM's revenue has grown year over year for six quarters in a row: $277M last quarter, up 29% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +9.9 points |
| Q2 2026 | 9.8% | +11 points |
| Q1 2026 | 2.2% | +9.1 points |
| Q4 2025 | 4.2% | +4.2 points |
| Q3 2025 | 2.9% | +0.7 points |
| Q2 2025 | -1.4% | +5 points |
| Q1 2025 | -6.8% | -13 points |
| Q4 2024 | 0% | -14 points |
ALGM's operating margin was 13% last quarter, up 9.9 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over ALGM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over ALGM on profitability, with a higher operating margin.
ALGM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $30.5M | +119% |
| Q2 2026 | $14M | -73% |
| Q1 2026 | $18.7M | +25% |
| Q4 2025 | $41.3M | +$63.1M |
| Q3 2025 | $13.9M | +150% |
| Q2 2025 | $51M | +120% |
| Q1 2025 | $15M | +$16.5M |
| Q4 2024 | -$21.8M | -157% |
ALGM generated $104M in free cash flow over the past year, up 80% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over ALGM on cash flow, with more consistent year-over-year improvement.
ALGM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -52.6K shares |
| 1 year | +0.8% | +1.4M shares |
| 3 years | -3.8% | -7.4M shares |
| 5 years | -2.1% | -4M shares |
| Available history | 0% | -32.5K shares |
ALGM has 188M diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | $116,000 |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over ALGM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
ALGM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 1.1x | Healthy |
| Q1 2026 | 1.4x | Healthy |
| Q4 2025 | 2.0x | Moderate |
| Q3 2025 | 3.1x | Elevated |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 5.0x | High |
| Q4 2024 | 3.0x | Moderate |
ALGM's net debt is less than a year of its operating earnings (EBITDA), down from 3.1 years a year ago.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over ALGM on leverage, with a lower net debt burden relative to earnings.
ALGM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.3 | Neutral |
| Stochastic | 13.9 | Oversold |
ALGM's weekly RSI is 41 (neutral) and its Stochastic is 14 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
ALGM PE vs Technology Sector
| Metric | ALGM | Sector median | Relative |
|---|---|---|---|
| PE | 198x | 28x | 611% above |
| PE % | 91 | 38 | 53 pts above |
ALGM is trading at 198x earnings, a 611% premium to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over ALGM on valuation relative to its sector.
ALGM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $33.2 | 4.4% below |
| 20 week MA | $38.9 | 18% below |
| 50 week MA | $38.7 | 18% below |
| 100 week MA | $32.9 | 3.7% below |
| 200 week MA | $32.4 | 2.2% below |
ALGM is in a downtrend: it's below all five of its weekly moving averages, and 2.2% below its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over ALGM on trend strength, trading above more of its moving averages.
ALGM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.3 | $24.8 | +35% |
| 2021 | $24.8 | $34.5 | +39% |
| 2022 | $34.5 | $30.2 | -12% |
| 2023 | $30.2 | $30.3 | +0.1% |
| 2024 | $30.3 | $22.3 | -26% |
| 2025 | $22.3 | $26.9 | +21% |
| 2026 YTD | $26.9 | $31.7 | +18% |
ALGM has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.